register

News & Trends - Pharmaceuticals

Boehringer Ingelheim’s dynamic evolution of ‘Life Forward’

Health Industry Hub | October 31, 2023 |

Pharma News: Boehringer Ingelheim has embarked on a transformative corporate rebrand, heralded by a vibrant new logo and a revitalised corporate colour palette. This shift encompasses not only a fresh visual identity but also the introduction of their inaugural brand slogan, Life Forward. The significance of this endeavour, as expressed by Boehringer’s Head of Corporate Affairs, extends far beyond a mere cosmetic alteration.

The company contemplates, “When future generations ask us to tell the story of how we tackled the most pressing challenges of our time, what will we say?”

This new direction takes root in the bedrock of the company’s overarching mission, encapsulated in the phrase ‘transforming lives for generations.’ It underscores how the corporation responds to the contemporary challenges of today and the unknown horizons of tomorrow, and the impact it aspires to create.

In a world grappling with non-communicable and infectious diseases, burgeoning aging populations, and healthcare systems pushed to their limits, the company takes on the task of addressing unmet medical needs. These critical areas encompass cardio-renal-metabolic (CRM) diseases, inflammation, oncology, and mental health.

Médard Schoenmaeckers, the Head of Corporate Affairs at Boehringer Ingelheim, firmly acknowledges the responsibility that comes with this role. “We have a responsibility to help address these challenges,” he stated. “Momentum to introduce our evolved brand has never been better with our well-stocked innovation pipeline that will make significant differences for both humans and animals.”

This evolution of the brand introduces a contemporary, digitally-driven brand experience. It takes inspiration from the company’s rich history as a family-owned enterprise, builds on their established record of pioneering collaborations, and amplifies their unwavering commitment to sustainability.

At the heart of this reimagined corporate brand lies a spirit of unwavering optimism. In everything we do and say, we look positively into the future because we know we can shape and influence it for the better and want to inspire others to join us,” added Mr Schoenmaeckers. “We have nearly 140 years of experience navigating the challenging dynamics of healthcare. And it is from that acquired resilience that we draw our confidence and the confidence that we can do better for the generations that come after us.”

Notably, other giants in the healthcare industry, such as Pfizer and the Johnson & Johnson Family of Companies, have also undertaken significant branding updates to remain in sync with the ever-evolving healthcare and consumer landscape.

Reimagining healthcare across the entire patient journey: Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change in healthcare.

The content on Health Industry Hub is copyright protected and can only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - Pharmaceuticals

Is the government is gearing up to release the long-awaited response to The New Frontier report?

Government’s long-awaited response to The New Frontier report unveiled after two-year wait

Health Industry Hub | December 1, 2023 |

Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]

More


News & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the 'unsung heroes'

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’

Health Industry Hub | December 1, 2023 |

Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]

More


News & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn's disease in seven years

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years

Health Industry Hub | December 1, 2023 |

Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]

More


ESG

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

Health Industry Hub | November 30, 2023 |

ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]

More


This content is copyright protected. Please subscribe to gain access.